Published: 2018-12-08

Articles

COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA

Monika Wagner, Mireille Goetghebeur, Elizabeth Merikle, Ankur Pandya, Paula Chu, Douglas CA Taylor
Abstract 277 | PDF Downloads 160
PDF

ACCESS AND INTENSITY OF USE OF PRESCRIPTION ANALGESICS AMONG OLDER MANITOBANS

Cheryl A Sadowski, Anita G Carrie, Ruby E Grymonpre, Colleen J Metge, Philip St.John
Abstract 220 | PDF Downloads 101
PDF

Innovations in Pharmacology - CSPT 2009 Conference Abstracts

Saskatoon, Saskatchewan
Abstract 163 | PDF Downloads 122
PDF

VALIDITY OF PERINATAL PHARMACOEPIDEMIOLOGIC STUDIES USING DATA FROM THE RAMQ ADMINISTRATIVE DATABASE

Anick Bérard, Anaïs Lacasse
Abstract 332 | PDF Downloads 196
PDF

CLINICAL EVALUATION OF DE MARCO FORMULA AS AN ADJUNCTIVE THERAPY FOR INFECTED ISCHEMIC DIABETIC FOOT: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

Héctor Álvarez Duarte, José I Fernández Montequín, Martha M Fors López, José Hernández Carretero, Miriam Mahia Vilas, Milagros García Mesa
Abstract 187 | PDF Downloads 92
PDF

THE UNINTENDED (AND COSTLY) EFFECTS DUE TO THE INTRODUCTION OF AN UNRESTRICTED REIMBURSEMENT POLICY FOR ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN A CANADIAN PUBLIC PRESCRIPTION DRUG PROGRAM: 1996/97 TO 2005/06

Daria J O’Reilly, Ron A Goeree, Jean-Eric Tarride, Colleen Janes, Patrick S Parfrey
Abstract 183 | PDF Downloads 94
PDF

VIDENCE AND VALUES: REQUIREMENTS FOR PUBLIC REIMBURSEMENT OF DRUGS FOR RARE DISEASES - A CASE STUDY IN ONCOLOGY

Michael Drummond, Bill Evans, Jacques LeLorier, Pierre Karakiewicz, Douglas Martin, Peter Tugwell, Stuart MacLeod
Abstract 584 | PDF Downloads 225
PDF

Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply

Andreas Laupacis
Abstract 174 | PDF Downloads 93
PDF

A Critical Review of: “Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications”

Ran D. Goldman
Abstract 114 | PDF Downloads 72
PDF

ETHYLGLUCURONIDE AND ETHYLSULFATE IN MECONIUM TO ASSESS GESTATIONAL ETHANOL EXPOSURE: PRELIMINARY RESULTS IN TWO MEDITERRANEAN COHORTS

Simona Pichini, Luca Morini, Emilia Marchei, Ilaria Palmi, Maria Concetta Rotolo, Federica Vagnarelli, Oscar Garcia-Algar, Oriol Val, Piergiorgio Zuccaro
Abstract 261 | PDF Downloads 146
PDF

WERE OUR FOREBEARS AWARE OF PRENATAL ALCOHOL EXPOSURE AND ITS EFFECTS? A REVIEW OF THE HISTORY OF FETAL ALCOHOL SPECTRUM DISORDER

James L Sanders
Abstract 531 | PDF Downloads 421
PDF

THE RELATION BETWEEN THEORY OF MIND AND EXECUTIVE FUNCTIONS IN CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS

Carmen Rasmussen, Katy Wyper, Victoria Talwar
Abstract 1371 | PDF Downloads 551
PDF